Ohio Public Employees Retirement System (OPERS)
TBPH icon

Ohio Public Employees Retirement System (OPERS)’s Theravance Biopharma TBPH Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-20,556
Closed -$184K – 2369
2025
Q1 		$184K Sell
20,556
-16,905
-45% -$157K ﹤0.01% 1658
2024
Q4 		$353K Buy
+37,461
New +$341K ﹤0.01% 1582
2014
Q3 		– Sell
-663
Closed -$21K – 1817
2014
Q2 		$21K Buy
+663
New +$20K ﹤0.01% 1781

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS)'s TBPH Position: Q2 2025 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Theravance Biopharma (TBPH) in Q2 2025, closing a stake of 20,556 shares — an estimated $184K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in TBPH in Q2 2014 and held it in 3 quarters. The position peaked at $353K in Q4 2024. 135 funds tracked by Wall St. Rank hold TBPH as of Q2 2025.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Theravance Biopharma position as of Q2 2025 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 20,556 Theravance Biopharma shares in Q2 2025, an estimated $184K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Theravance Biopharma in Q2 2014 and held it in 3 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s Theravance Biopharma position peaked at $353K in Q4 2024.
  • 135 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2025.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2025, filed 15 Jul 2025.